| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein phosphatase 1 catalytic subunit beta | 0.601 | 0.577 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
cyclin dependent kinase like 5 | 0.522 | 0.692 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
WW domain containing oxidoreductase | 0.453 | 0.808 | 1.2E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
SH3 and multiple ankyrin repeat domains 3 | 0.550 | 0.731 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
calcium/calmodulin dependent serine protein kinase | 0.538 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
proline rich transmembrane protein 2 | 0.448 | 0.808 | 0.58 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
leucine rich glioma inactivated 1 | 0.568 | 0.731 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
calpain 2 | 0.590 | 0.692 | 3.5E-22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
G protein subunit beta 5 | 0.736 | 0.308 | 6.4E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
WD repeat domain 45 | 0.647 | 0.423 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
solute carrier family 35 member A2 | 0.525 | 0.808 | 0.72 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
CAP-Gly domain containing linker protein 1 | 0.617 | 0.654 | 0.68 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ezrin | 0.476 | 0.808 | 0.18 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
lines homolog 1 | 0.691 | 0.231 | 2.4E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
formin 2 | 0.610 | 0.538 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.527 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
chromosome 12 open reading frame 4 | 0.691 | 0.308 | 1.1E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
seryl-tRNA synthetase 1 | 0.558 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | 0.606 | 0.654 | 2.6E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
F-box protein 31 | 0.653 | 0.423 | 0.44 |
|
disease | 0.100 | None | 0 | 0 |